Retrophin, Inc. Announces Changes To Board Of Directors And Management Team

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Retrophin, Inc. (NASDAQ:RTRX) today announced that Jeffrey Paley, MD has stepped down as a member of the Board of Directors to more fully devote time to his medical practice, and Marc Panoff has decided to leave his role as Chief Financial Officer (CFO) to pursue other career opportunities. Mr. Panoff will continue overseeing financial operations until a CFO replacement is in place. The Company has initiated searches to identify a new independent director and CFO.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC